Literature DB >> 17880565

Prolonged response times characterize cognitive performance in multiple sclerosis.

A Achiron1, G M Doniger, Y Harel, N Appleboim-Gavish, M Lavie, E S Simon.   

Abstract

Cognitive impairment is amongst the main symptoms affecting multiple sclerosis (MS) and should be comprehensively and accurately assessed. To study the added value of a computerized neuropsychological battery enabling the measurement of response times in the cognitive domains, 58 randomly selected MS patients and 71 age-, gender- and education-matched healthy subjects were evaluated. Construct and discriminant validity were assessed for the standard Neuropsychological Screening Battery for Multiple Sclerosis (NSBMS) and the Mindstreams Computerized Cognitive Battery (MCCB). The MCCB demonstrated good construct validity in comparison with the NSBMS in memory (P < 0.001), executive function (P < 0.001), attention (P < 0.05) and information processing (P < 0.05) domains. In addition, it showed high discriminant validity most prominently for executive function, attention and motor skills (P < 0.001). Response times measured by the computerized battery were longer in all cognitive domains and varied with cognitive load, demonstrating that response time deficits in MS are associated with particular task demands. We conclude that in MS prolonged response times on a range of cognitive tasks signify abnormal conduction within demyelinative tracts.

Entities:  

Mesh:

Year:  2007        PMID: 17880565     DOI: 10.1111/j.1468-1331.2007.01909.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  20 in total

1.  Gait and cognitive impairments in multiple sclerosis: the specific contribution of falls and fear of falling.

Authors:  Alon Kalron; Gilles Allali
Journal:  J Neural Transm (Vienna)       Date:  2017-07-22       Impact factor: 3.575

2.  Metallic gold slows disease progression, reduces cell death and induces astrogliosis while simultaneously increasing stem cell responses in an EAE rat model of multiple sclerosis.

Authors:  Dan Sonne Pedersen; Pil Møntegaard Fredericia; Mie Ostergaard Pedersen; Meredin Stoltenberg; Milena Penkowa; Gorm Danscher; Jørgen Rungby; Agnete Larsen
Journal:  Histochem Cell Biol       Date:  2012-07-22       Impact factor: 4.304

3.  NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis.

Authors:  Richard A Sater; Mark Gudesblatt; Kiren Kresa-Reahl; David W Brandes; Pamela Sater
Journal:  Int J MS Care       Date:  2016 Jul-Aug

4.  The relationship between gait variability and cognitive functions differs between fallers and non-fallers in MS.

Authors:  Alon Kalron; Roy Aloni; Mark Dolev; Lior Frid; Uri Givon; Shay Menascu
Journal:  J Neural Transm (Vienna)       Date:  2018-01-19       Impact factor: 3.575

5.  Motoric cognitive risk syndrome in people with multiple sclerosis: prevalence and correlations with disease-related factors.

Authors:  Sapir Dreyer-Alster; Shay Menascu; Roy Aloni; Uri Givon; Mark Dolev; Anat Achiron; Alon Kalron
Journal:  Ther Adv Neurol Disord       Date:  2022-07-04       Impact factor: 6.430

6.  Cerebellum and cognition in multiple sclerosis: the fall status matters.

Authors:  Alon Kalron; Gilles Allali; Anat Achiron
Journal:  J Neurol       Date:  2018-02-02       Impact factor: 4.849

7.  Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome.

Authors:  Belgin Kocer; Tugba Unal; Bijen Nazliel; Zeynep Biyikli; Zulal Yesilbudak; Sirel Karakas; Ceyla Irkec
Journal:  Neurol Sci       Date:  2008-11-11       Impact factor: 3.307

8.  Overall Memory Impairment Identification with Mathematical Modeling of the CVLT-II Learning Curve in Multiple Sclerosis.

Authors:  Igor I Stepanov; Charles I Abramson; Marietta Hoogs; Ralph H B Benedict
Journal:  Mult Scler Int       Date:  2012-04-29

9.  Executive function and falls in older adults: new findings from a five-year prospective study link fall risk to cognition.

Authors:  Anat Mirelman; Talia Herman; Marina Brozgol; Moran Dorfman; Elliot Sprecher; Avraham Schweiger; Nir Giladi; Jeffrey M Hausdorff
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

10.  Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.

Authors:  Anat Achiron; Joab Chapman; David Magalashvili; Mark Dolev; Mor Lavie; Eran Bercovich; Michael Polliack; Glen M Doniger; Yael Stern; Olga Khilkevich; Shay Menascu; Gil Hararai; Micharel Gurevich; Yoram Barak
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.